Mindbloom Is Now Available in Five New States

Medically reviewed by 
Published on 
March 12, 2021
Updated on 

Expanding access to at-home ketamine therapy is one of Mindbloom’s core objectives, which we're achieving by making access to treatment more approachable, affordable, and available.

Today, we’re proud to announce a big milestone in treatment availability: 50% coverage of the U.S. population.

You now have access to a team of licensed psychiatric clinicians, and dedicated Mindbloom Guides, who will provide personalized, transformational treatment experiences in the comfort and safety of your own home. This means no long drives to in-person appointments, no cramped waiting rooms, and no providers who have limited mental healthcare experience.

The level of care we provide speaks for itself: Over 90% of Mindbloom clients report improvement in anxiety or depression symptoms following Mindbloom treatment.

If you —or anyone you know— may benefit from working with Mindbloom, take our brief assessment to see if you’re a candidate.

For future coverage and Mindbloom announcements, follow us on Instagram and check back here on our blog for more details.

Want to be a part of our mission to expand access to these transformational client experiences? Join our team of mission-obsessed clinicians, guides, and technologists, who are building a unique company Culture of Consciousness.


This article is for informational purposes only and is not intended to be a substitute for professional medical advice. Always talk to your doctor about the risks and benefits of any treatment. If you are in a life-threatening situation, call the National Suicide Prevention Line at +1 (800) 273-8255, call 911, or go to the nearest emergency room.

Important FDA Safety Information

Ketamine is not FDA-approved for the treatment of depression or anxiety. Learn more about off-label uses here.

Side effects of ketamine treatment may include: altered sense of time, anxiety, blurred vision, diminished ability to see/hear/feel, dry mouth, elevated blood pressure or heart rate, elevated intraocular or intracranial pressure, excitability, loss of appetite, mental confusion, nausea/vomiting, nystagmus (rapid eye movements), restlessness, slurred speech, synesthesia (a mingling of the senses).

Do not proceed with ketamine treatment if any of the following apply to you:

  • Allergic to ketamine
  • Symptoms of psychosis or mania
  • Uncontrolled high blood pressure
  • CHF or other serious heart problem
  • Severe breathing problem
  • History of elevated intraocular or intracranial pressure
  • History of hyperthyroidism
  • Other serious medical illness
  • Pregnant, nursing, or trying to become pregnant

Ketamine has been reported to produce issues including, but not limited to, those listed below. However, lasting adverse side-effects are rare when medical protocols are carefully followed.

While ketamine has not been shown to be physically addictive, it has been shown to cause moderate psychological dependency in some recreational users.

  • In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
  • Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders.
  • Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your MindBloom® clinician before proceeding with treatment.
  • The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents.

To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:

  • Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
  • Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
  • Continue to take antihypertensive medication as prescribed
  • Avoid hangovers or alcohol intake
  • Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
  • Ketamine treatment should never be conducted without a monitor present to ensure your safety

Questions? Chat With an Exploratory Guide

Take our brief assessment, and speak with an expert who will help ensure psychedelic treatment matches your goals.

Take the AssessmentTake the Assessment